January 26, 2022 – Ontada®, a McKesson business focused on oncology provider technology solutions, targeted channels for biopharmaceutical and provider engagement, and a research arm focused on clinical data and evidence solutions, announced today the appointment of Viraj Narayanan as Chief Commercial Officer. The new position will be responsible for developing an aligned strategy to support the success of biopharmaceutical and provider partners and drive integrated, sustainable and profitable growth for Ontada.
In his role, Narayanan will oversee commercial operations from go-to-market strategy through commercial execution. He will also be responsible for developing and executing a unified strategy for Ontada’s business to support community-based oncologists with technologies designed to enhance care delivery, while at the same time providing our biopharmaceutical partners with evidence and solutions that can be used for both internal and external decision making.
“We are excited that Viraj will be joining Ontada,” said Susan Shiff, president, Ontada. “His extensive experience working at the intersection of oncology real-world data, technology and life sciences will help lead our continued growth with both biopharmaceutical companies and oncology providers, and provide value to patients, providers, regulators, and payers.”